<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03152240</url>
  </required_header>
  <id_info>
    <org_study_id>TAPAC study</org_study_id>
    <nct_id>NCT03152240</nct_id>
  </id_info>
  <brief_title>Coronary Anatomy Study and Times Since the Onset of Acute Myocardial Infarction Symptoms in Women Until the Opening of the Artery (TAPAC Study)</brief_title>
  <acronym>TAPAC</acronym>
  <official_title>Coronary Anatomy Study and Times Since the Onset of Acute MyocardiaI Infarction Symptoms in Women Until the Opening of the Artery (TAPAC Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TAPAC study is an an investigator-driven, observational, prospective,cohort aimed at
      evaluating differences between men and women in patients undergoing primary angioplasty :
      hospital medical care, successful markers myocardial reperfusion and the anatomical substrate
      by describing the underlying coronary anatomy will be compared.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TAPAC study is an an investigator-driven, observational, prospective,cohort aimed at
      evaluating differences between men and women in patients undergoing primary angioplasty :
      hospital medical care, successful markers myocardial reperfusion and the anatomical substrate
      by describing the underlying coronary anatomy will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Door-to-balloon time in patients</measure>
    <time_frame>90 minutes</time_frame>
    <description>Door-to-balloon time in patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Door-to-needle time in patients</measure>
    <time_frame>90 minutes</time_frame>
    <description>Door-to-balloon time in patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from onset of chest pain to first medical care</measure>
    <time_frame>24 hours</time_frame>
    <description>Time from onset of chest pain to first medical care</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from onset of chest pain to arrival Cath Lab</measure>
    <time_frame>24 hours</time_frame>
    <description>Time from onset of chest pain to arrival Cath Lab</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from onset of chest pain to artery opening</measure>
    <time_frame>24 hours</time_frame>
    <description>Time from onset of chest pain to artery opening</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Markers successful myocardial reperfusion by angiography</measure>
    <time_frame>First 90 min after reperfusion.</time_frame>
    <description>ST segment resolution 90 minutes post-PCI (Percutaneous Coronary Intervention)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Markers successful myocardial reperfusion by angiography</measure>
    <time_frame>First 90 min after reperfusion.</time_frame>
    <description>Final TIMI (Thrombolysis in Myocardial Infarction) flow grade</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Markers successful myocardial reperfusion by angiography</measure>
    <time_frame>First 90 min after reperfusion.</time_frame>
    <description>Final TIMI blush grade</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Underlying coronary anatomy assessment</measure>
    <time_frame>24 hours</time_frame>
    <description>Final TIMI Thrombus grade</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Underlying coronary anatomy assessment</measure>
    <time_frame>24 hours</time_frame>
    <description>Degree of difuse disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Underlying coronary anatomy assessment</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of vessels involve</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Underlying coronary anatomy assessment</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of Ventricular Ejection Fraction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Underlying coronary anatomy assessment</measure>
    <time_frame>24 hours</time_frame>
    <description>Presence of significant Left Main disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Underlying coronary anatomy assessment</measure>
    <time_frame>24 hours</time_frame>
    <description>Degree of distal embolization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events (MACE)</measure>
    <time_frame>Hospital discharge and expected average of 1 week, one year follow-up</time_frame>
    <description>MACE rate during hospitalization, defined as death, non-fatal myocardial rupture, or appearance or worsening of heart failure during the hospitalization period and after 1 year of follow-up</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Women patients</arm_group_label>
    <description>Women patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Men patients</arm_group_label>
    <description>Men patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non intervention</intervention_name>
    <description>Non intervention</description>
    <arm_group_label>Women patients</arm_group_label>
    <arm_group_label>Men patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men and women undergoing coronary angioplasty.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with:

          -  Aged 18 years or over.

          -  AMI (Acute Mycardial Infarction ) with ST segment elevation and indication of primary
             angioplasty in whom at least one diagnostic procedure with coronary angiography is
             performed.

        Exclusion Criteria:

        Patients with:

          -  Life expectancy of less than one year.

          -  Previous AMI.

          -  Previous coronary revascularization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruno García del Blanco, MD, PhD</last_name>
    <phone>+34 93 274 61 55</phone>
    <email>brunogb51@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bruno García del Blanco</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Vall d`Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016 Jan 26;133(4):447-54. doi: 10.1161/CIR.0000000000000366.</citation>
    <PMID>26811276</PMID>
  </reference>
  <reference>
    <citation>2. World Health Organization.The European Health Report2012: Chartingthe Wayto Well-being. Copenhagen, Denmark: World Health Organization Regional Office for Europe;2012</citation>
  </reference>
  <reference>
    <citation>Dégano IR, Salomaa V, Veronesi G, Ferriéres J, Kirchberger I, Laks T, Havulinna AS, Ruidavets JB, Ferrario MM, Meisinger C, Elosua R, Marrugat J; Acute Myocardial Infarction Trends in Europe (AMITIE) Study Investigators. Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations. Heart. 2015 Sep;101(17):1413-21. doi: 10.1136/heartjnl-2014-307310. Epub 2015 Apr 8.</citation>
    <PMID>25855798</PMID>
  </reference>
  <reference>
    <citation>Garcia-Dorado D, Garcia del Blanco B. Door-to-balloon time and mortality. N Engl J Med. 2014 Jan 9;370(2):179. doi: 10.1056/NEJMc1313113.</citation>
    <PMID>24401062</PMID>
  </reference>
  <reference>
    <citation>Pancholy SB, Shantha GP, Patel T, Cheskin LJ. Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med. 2014 Nov;174(11):1822-30. doi: 10.1001/jamainternmed.2014.4762. Review.</citation>
    <PMID>25265319</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>February 15, 2018</last_update_submitted>
  <last_update_submitted_qc>February 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Primary Angioplasty</keyword>
  <keyword>Gender</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

